PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

AbbVie’s Qulipta gains edge on Pfizer’s Nurtec with FDA approval to prevent chronic migraines

AbbVie’s Qulipta has gained an edge in the heated migraine market thanks to a new approval to prevent chronic migraines. The new FDA nod makes the pill the only o...
Continue Reading →
News

STERILINE’S EFFORTS IN R&D INNOVATION EXHIBITED AT INTERPACK 2023

Volumetric pump assembly system and servo platform filling machine as flagship solutions presented at the trade show Steriline[A1] , the well-established Eur...
Continue Reading →
News

MSD’s Keytruda given go-ahead by SMC

Treatment concerns adults and adolescents with stage IIB or IIC melanoma skin cancer MSD's Keytruda has received a recommendation from the Scottish Medicines Cons...
Continue Reading →
News

Moderna cancer vaccine takes a positive step

The company’s candidate, in combination with MSD’s Keytruda, receives a PRIME designation. Moderna has announced that mRNA-4157/V940 – its investigational cancer ...
Continue Reading →
News

FTC review slows Sanofi’s Provention Buyout

Sanofi has withdrawn and refiled its pre-merger notification and report form in connection with its pending acquisition of Provention Bio in order to provide the Fed...
Continue Reading →
News

Astellas, Veneno Technologies enter research agreement

Japanese-based companies Astellas and Veneno Technologies announced this week that they have entered a joint research agreement to develop functional peptides (DRPs)...
Continue Reading →
News

AbbVie and J&J withdraw two cancer approvals for a blockbuster drug

AbbVie announced its plans to voluntarily withdraw the FDA’s accelerated approval for Imbruvica in two blood cancer indications — mantle cell lymphoma (MCL) and refra...
Continue Reading →
News

L.B. Bohle at INTERPHEX

L.B. Bohle, the most innovative technology company in the design and implementation of machines and processes for the production of pharmaceutical solids, will...
Continue Reading →
News

Adcendo funding boosts antibody-drug conjugates development

Funds will be used to ensure the wider pan-sarcoma development of lead candidate uPARAP Adcendo – a company that concentrates on the development of breakthrough a...
Continue Reading →
News

iOmx doses first patient in pivotal phase 1 study

The study becomes the first-in-human clinical trial involving OMX-0407 in a specific patient group. iOmx Therapeutics – a company developing targeted cancer immun...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026